A Randomized, Double-Blind Phase 3 Study of Ibrutinib in Combination With Corticosteroids versus Placebo in Combination With Corticosteroids in Subjects with New Onset Chronic Graft Versus Host Disease (cGVHD)

Sponsor
Pharmacyclics

Protocol Number
PCYC-1140-IM

To Learn More Call
201-510-0910